Cargando…

Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa

Placenta accreta spectrum (PAS) disorder often causes a large amount of intraoperative bleeding in a short period which makes maternal circulation unstable and threatens life. As a countermeasure, two-stage surgery combined with selective uterine arterial embolization (UAE), named “stepwise treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumigama, Seiji, Kotani, Tomomi, Hayakawa, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752196/
https://www.ncbi.nlm.nih.gov/pubmed/35036544
http://dx.doi.org/10.1055/s-0041-1728748
_version_ 1784631836320727040
author Sumigama, Seiji
Kotani, Tomomi
Hayakawa, Hiromi
author_facet Sumigama, Seiji
Kotani, Tomomi
Hayakawa, Hiromi
author_sort Sumigama, Seiji
collection PubMed
description Placenta accreta spectrum (PAS) disorder often causes a large amount of intraoperative bleeding in a short period which makes maternal circulation unstable and threatens life. As a countermeasure, two-stage surgery combined with selective uterine arterial embolization (UAE), named “stepwise treatment” was introduced in 2003. At a cesarean section (CS), only the baby is delivered and the placenta is left in situ. The transcatheter angiographic UAE is performed on the operation day, followed by the total hysterectomy on 5 to 7 days after CS. The difficulty in the operative procedures for hysterectomy and the amount of bleeding can be reduced by the added effect of the blood flow interruption by UAE and the uterine involution. Although there are not many indication cases, this is the prudent operation that should be considered for the most severe PAS case such as total placenta increta/percreta with placenta previa. In this article, the practical procedures and tips of stepwise treatment are described.
format Online
Article
Text
id pubmed-8752196
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical Publishers, Inc.
record_format MEDLINE/PubMed
spelling pubmed-87521962022-01-13 Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa Sumigama, Seiji Kotani, Tomomi Hayakawa, Hiromi Surg J (N Y) Placenta accreta spectrum (PAS) disorder often causes a large amount of intraoperative bleeding in a short period which makes maternal circulation unstable and threatens life. As a countermeasure, two-stage surgery combined with selective uterine arterial embolization (UAE), named “stepwise treatment” was introduced in 2003. At a cesarean section (CS), only the baby is delivered and the placenta is left in situ. The transcatheter angiographic UAE is performed on the operation day, followed by the total hysterectomy on 5 to 7 days after CS. The difficulty in the operative procedures for hysterectomy and the amount of bleeding can be reduced by the added effect of the blood flow interruption by UAE and the uterine involution. Although there are not many indication cases, this is the prudent operation that should be considered for the most severe PAS case such as total placenta increta/percreta with placenta previa. In this article, the practical procedures and tips of stepwise treatment are described. Thieme Medical Publishers, Inc. 2021-09-30 /pmc/articles/PMC8752196/ /pubmed/35036544 http://dx.doi.org/10.1055/s-0041-1728748 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Sumigama, Seiji
Kotani, Tomomi
Hayakawa, Hiromi
Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa
title Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa
title_full Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa
title_fullStr Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa
title_full_unstemmed Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa
title_short Stepwise Treatment for Abnormally Invasive Placenta with Placenta Previa
title_sort stepwise treatment for abnormally invasive placenta with placenta previa
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752196/
https://www.ncbi.nlm.nih.gov/pubmed/35036544
http://dx.doi.org/10.1055/s-0041-1728748
work_keys_str_mv AT sumigamaseiji stepwisetreatmentforabnormallyinvasiveplacentawithplacentaprevia
AT kotanitomomi stepwisetreatmentforabnormallyinvasiveplacentawithplacentaprevia
AT hayakawahiromi stepwisetreatmentforabnormallyinvasiveplacentawithplacentaprevia